Back to articles
    Vehicle and Solvent Controls in In Vitro Peptide Work: The Comparison That Makes a Result Interpretable

    18 November 2026

    Vehicle and Solvent Controls in In Vitro Peptide Work: The Comparison That Makes a Result Interpretable

    More than half of the 1,576 researchers Nature surveyed on reproducibility reported having failed to reproduce their own experiments. That figure is harder to explain away than the better-known 70 per cent who could not reproduce someone else's work, because the usual explanations, undisclosed method differences and selective reporting, do not apply when a laboratory is repeating itself. What remains is the set of variables a protocol does not record, and the composition of the vehicle a compound was delivered in is one of the largest of them.

    A vehicle control is the comparison that isolates the compound's contribution from the contribution of everything it arrived with. It is the cheapest control in the experiment and the one most often run inadequately, usually because it is run at the wrong concentration.

    What the vehicle actually contains

    A peptide reaching an assay well brings more than itself, and the components are measurable rather than hypothetical.

    The organic solvent used to achieve initial solubility is the largest contributor for hydrophobic sequences. Dimethyl sulfoxide is the common choice and it is not biologically inert at concentrations that are easy to reach accidentally. The proportion arriving in the well depends on the stock concentration and the dilution factor, and because the final solvent proportion is the thing that matters rather than the volume added, it is easy to vary it between conditions without noticing.

    Counterion arrives with the solid. Synthetic peptides purified by reverse-phase chromatography are commonly isolated as trifluoroacetate salts, and the counterion is a real fraction of the delivered weight. It is not an inert passenger in a biological system.

    Residual solvent from synthesis and purification travels with the lyophilised material and varies between lots.

    Carrier proteins and additives, where present in a formulation, are deliberate inclusions intended to reduce adsorptive loss, and they are additionally a protein load the assay now contains.

    Buffer components from the diluent contribute ionic strength, pH and osmotic concentration, each capable of producing a cellular response on its own.

    Why one control well is not enough

    The common implementation is a single vehicle well matched to the highest test concentration. It is better than nothing and it answers the wrong question.

    In a concentration-response series, the vehicle proportion is usually not constant. If a serial dilution of the compound is prepared in aqueous buffer from an organic stock, the solvent proportion falls with each step. The lowest test concentration therefore carries the least solvent, and the highest carries the most. A single control at the top concentration establishes that the solvent is tolerable at its maximum and tells you nothing about whether the apparent concentration-response relationship is partly a solvent gradient.

    The robust arrangement is to hold the vehicle proportion constant across every condition, by preparing the dilution series in the solvent itself and then diluting all conditions identically into the assay. Where that is impractical, the alternative is a matched vehicle control at every step of the series, which costs more wells and answers the question properly.

    The distinction matters because a solvent gradient and a concentration-response curve have the same shape. One of them is the experiment.

    The controls that are usually missing

    Beyond the solvent, three comparisons are worth running when a result is load-bearing.

    A counterion control, using the salt alone at the proportion present in the test condition, separates the compound's contribution from its counterion's. This is rarely run and is the most informative of the three for trifluoroacetate salts.

    A lot control, meaning the same experiment performed with a retained portion of a previous lot, distinguishes a material change from an experimental one. The published work on reagent variability across 1,323 antibody lots found a median lot-to-lot variation of 3.8 per cent with a tail exceeding 20 per cent in 8.8 per cent of cases and 30 per cent in 3.6 per cent. Most lots are comparable; a minority are not, and only a retained portion lets a laboratory tell which case it is in.

    A diluent control that matches the working buffer exactly, including its measured osmotic concentration and pH at the working temperature, rather than a nominally identical buffer prepared separately. Two buffers with the same name and the same recipe can differ in osmolality, in trace metal content and in the grade of water used to make them.

    What the protocol should record

    None of this is recoverable retrospectively, which is why the record matters as much as the controls.

    A method section that supports replication states the stock concentration and the solvent it was prepared in, the final solvent proportion in the assay, the diluent with its measured pH and osmotic concentration, the compound lot number, and the interval between preparation and use. That is six short pieces of information, each of which is known at the bench and almost none of which survives into a typical write-up.

    The asymmetry is stark. A paper will describe a compound by supplier and catalogue number, which identifies a product line, and omit the lot, which identifies the material. It will name the solvent and omit the final proportion, which is the quantity that determines whether the solvent had an effect.

    How it works in practice

    For a purchaser, the relevant question is which of these variables the supplier has made knowable.

    Counterion identity and content, residual solvent, water content and whether the stated quantity is fill weight or peptide content are all properties a certificate can disclose and many do not. Where they are disclosed, a laboratory can design its vehicle controls to match what is actually present. Where they are not, the controls are being designed against an assumption.

    For a research compound such as Bluum Peptides eloralintide, supplied for laboratory research use, the practical checks before an order are therefore narrow: is the salt form stated, is peptide content given separately from total fill, and is water content reported on a lot-specific basis. For laboratory research use only. Not for human or veterinary use. Those three answers determine whether the vehicle control in the first experiment is matched to the material or to a guess about it.

    Solubility guidance from the supplier is worth asking for in the same message, because the choice of organic solvent and the achievable stock concentration together set the final solvent proportion the assay will have to tolerate.

    Where this is heading

    Reporting standards have moved towards reagent identification at the lot level, and the logic extends naturally to preparation: a reagent identified precisely but prepared undescribably has not been specified.

    Some journals now ask for solvent proportion explicitly in assay descriptions, which is a recent and useful development. It remains inconsistent, and in the absence of a requirement the discipline sits with the laboratory.

    The practical argument for adopting it anyway is the figure at the top of this article. An unrecorded vehicle composition is exactly the kind of variable that changes quietly between two runs of the same protocol, months apart, performed by the same people, and leaves no trace in the data to explain why the second run did not match the first.

    Conclusion

    A compound arrives with an organic solvent, a counterion, residual solvent, possibly a carrier protein, and a buffer, and each of those has biological activity of its own at concentrations that are easy to reach without intending to.

    The controls that separate them are cheap. Hold the vehicle proportion constant across the whole concentration series rather than controlling only the top of it. Run a counterion control where the result matters. Retain a portion of the lot so that a future discrepancy can be tested rather than argued about. And write down the stock concentration, the final solvent proportion, the diluent and the lot, because those four lines are the difference between a protocol another laboratory can follow and a description of something that happened once.